XML 15 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2024
Mar. 21, 2025
Jun. 28, 2024
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2024    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2024    
Current Fiscal Year End Date --12-31    
Entity File Number 001-41282    
Entity Registrant Name SUNSHINE BIOPHARMA INC.    
Entity Central Index Key 0001402328    
Entity Tax Identification Number 20-5566275    
Entity Incorporation, State or Country Code CO    
Entity Address, Address Line One 333 Las Olas Way    
Entity Address, Address Line Two CU4 Suite 433    
Entity Address, City or Town Fort Lauderdale    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 33301    
City Area Code 954    
Local Phone Number 330-0684    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 22,618,055
Entity Common Stock, Shares Outstanding   2,707,541  
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Auditor Name Bush & Associates CPA LLC    
Auditor Location Henderson, Nevada    
Auditor Firm ID 6797    
Common Stock [Member]      
Title of 12(b) Security Common Stock, par value $0.001    
Trading Symbol SBFM    
Security Exchange Name NASDAQ    
Warrant [Member]      
Title of 12(b) Security Warrants    
Trading Symbol SBFMW    
Security Exchange Name NASDAQ